avatar for Martin Ho

Martin Ho

Associate Director, Office of Biostatistics and Epidemiology, CBER
Mr. Martin Ho is Associate Director of Quantitative Patient Inputs & Real-World Patient Evidence at Office of Biostatistics & Epidemiology, CBER, US FDA. Prior, he was the Director of Quantitative Innovation at Center for Devices, turning new data sources into regulatory-grade evidence for decision making, e.g., developing good review practices and review capacity for patient preference information and clinical outcome assessments. He was building Real-World Performance component of Digital Health Program. Mr. Ho was President of FDA Statistical Association (2016). He was elected as Chair (2020) of American Statistical Association (ASA) Medical Device & Diagnostic Section and co-leads the ASA Real-World Evidence Scientific Working Group.